Found: 4
Select item for more details and to access through your institution.
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 798, doi. 10.1111/dom.13958
- By:
- Publication type:
- Article
N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2899, doi. 10.1111/dom.13465
- By:
- Publication type:
- Article
Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 9, p. 1570, doi. 10.1093/ndt/gfz064
- By:
- Publication type:
- Article
Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials.
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, n. 10, p. 1699, doi. 10.1093/ndt/gfy159
- By:
- Publication type:
- Article